MIM
RAPP

MetLife Investment Management’s Rapport Therapeutics RAPP Stock Holding History

MetLife Investment Management’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$501K Hold
15,996
– – ﹤0.01% 1755
2025
Q4 		$485K Buy
15,996
+5,133
+47% +$142K ﹤0.01% 1802
2025
Q3 		$323K Hold
10,863
– – ﹤0.01% 2039
2025
Q2 		$124K Hold
10,863
– – ﹤0.01% 2435
2025
Q1 		$109K Buy
10,863
+5,153
+90% +$66.9K ﹤0.01% 2487
2024
Q4 		$101K Hold
5,710
– – ﹤0.01% 2619
2024
Q3 		$117K Buy
+5,710
New +$123K ﹤0.01% 2567

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return